Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $1.13 Million - $1.31 Million
-12,200 Reduced 82.43%
2,600 $276,000
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $685,944 - $780,984
7,200 Added 94.74%
14,800 $1.43 Million
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $9,227 - $10,154
100 Added 1.33%
7,600 $767,000
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $9,473 - $10,513
100 Added 1.35%
7,500 $763,000
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $684,648 - $776,334
7,400 New
7,400 $746,000
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $320,440 - $362,480
4,000 New
4,000 $351,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $551,100 - $649,902
-6,600 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $195,174 - $236,075
-2,500 Reduced 27.47%
6,600 $623,000
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $49,284 - $54,600
600 Added 7.06%
9,100 $791,000
Q2 2020

Sep 10, 2020

BUY
$80.93 - $91.1 $291,348 - $327,960
3,600 Added 73.47%
8,500 $742,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $1.94 Million - $2.72 Million
-27,500 Reduced 84.88%
4,900 $404,000
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $1.02 Million - $1.15 Million
-12,100 Reduced 27.19%
32,400 $3.07 Million
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $377,000 - $464,000
-5,000 Reduced 10.1%
44,500 $4.06 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $2.73 Million - $3.16 Million
-40,800 Reduced 45.18%
49,500 $4.27 Million
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $3.39 Million - $3.83 Million
52,200 Added 137.01%
90,300 $6.82 Million
Q1 2018

May 15, 2018

BUY
$70.39 - $84.15 $2.28 Million - $2.73 Million
32,400 Added 568.42%
38,100 $3.08 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $412,281 - $442,548
5,700
5,700 $479,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.